Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study
Tài liệu tham khảo
Autier, 2014, Vitamin D status and ill health: a systematic review, Lancet Diabetes Endocrinol, 2, 76, 10.1016/S2213-8587(13)70165-7
Bolland, 2014, The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis, Lancet Diabetes Endocrinol, 2, 307, 10.1016/S2213-8587(13)70212-2
Tamez, 2012, Vitamin D and hypertension: an update and review, Curr Opin Nephrol Hypertens, 21, 492, 10.1097/MNH.0b013e3283557bf0
Margolis, 2008, Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative randomized trial, Hypertension, 52, 847, 10.1161/HYPERTENSIONAHA.108.114991
Witham, 2009, Effect of vitamin D on blood pressure: a systematic review and meta-analysis, J Hypertens, 27, 1948, 10.1097/HJH.0b013e32832f075b
Forman, 2013, Effect of vitamin D supplementation on blood pressure in blacks, Hypertension, 61, 779, 10.1161/HYPERTENSIONAHA.111.00659
Elamin, 2011, Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis, J Clin Endocrinol Metab, 96, 1931, 10.1210/jc.2011-0398
Davey Smith, 2003, ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?, Int J Epidemiol, 32, 1, 10.1093/ije/dyg070
Wang, 2010, Common genetic determinants of vitamin D insufficiency: a genome-wide association study, Lancet, 376, 180, 10.1016/S0140-6736(10)60588-0
Berry, 2012, Evaluation of genetic markers as instruments for mendelian randomization studies on vitamin D, PLoS One, 7, e37465, 10.1371/journal.pone.0037465
Vimaleswaran, 2013, Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts, PLoS Med, 10, e1001383, 10.1371/journal.pmed.1001383
Chun, 2010, Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D, J Clin Endocrinol Metab, 95, 3368, 10.1210/jc.2010-0195
Jones, 2012, 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D, Arch Biochem Biophys, 523, 9, 10.1016/j.abb.2011.11.003
Ehret, 2011, Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk, Nature, 478, 103, 10.1038/nature10405
Newton-Cheh, 2009, Genome-wide association study identifies eight loci associated with blood pressure, Nat Genet, 41, 666, 10.1038/ng.361
Levy, 2009, Genome-wide association study of blood pressure and hypertension, Nat Genet, 41, 677, 10.1038/ng.384
Jones, 1998, Current understanding of the molecular actions of vitamin D, Physiol Rev, 78, 1193, 10.1152/physrev.1998.78.4.1193
1995
Palmer, 2012, Using multiple genetic variants as instrumental variables for modifiable risk factors, Stat Methods Med Res, 21, 223, 10.1177/0962280210394459
Lawlor, 2008, Mendelian randomization: using genes as instruments for making causal inferences in epidemiology, Stat Med, 27, 1133, 10.1002/sim.3034
Thomas, 2007, Re: Estimation of bias in nongenetic observational studies using “Mendelian triangulation” by Bautista et al, Ann Epidemiol, 17, 511, 10.1016/j.annepidem.2006.12.005
Kunutsor, 2014, Vitamin D and high blood pressure: causal association or epiphenomenon?, Eur J Epidemiol, 29, 1, 10.1007/s10654-013-9874-z
Pittas, 2010, Systematic review: vitamin D and cardiometabolic outcomes, Ann Intern Med, 152, 307, 10.7326/0003-4819-152-5-201003020-00009
Witham, 2013, Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial, JAMA Intern Med, 173, 1672
Kupferschmidt, 2012, Uncertain verdict as vitamin D goes on trial, Science, 337, 1476, 10.1126/science.337.6101.1476
Freundlich, 2008, Suppression of renin-angiotensin gene expression in the kidney by paricalcitol, Kidney Int, 74, 1394, 10.1038/ki.2008.408
Li, 2002, 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system, J Clin Invest, 110, 229, 10.1172/JCI0215219
Schroten, 2013, Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial), Am Heart J, 166, 357, 10.1016/j.ahj.2013.05.009
Tiosano, 2011, The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR), J Bone Miner Res, 26, 2252, 10.1002/jbmr.431
Mehrotra, 2009, Chronic kidney disease, hypovitaminosis D, and mortality in the United States, Kidney Int, 76, 977, 10.1038/ki.2009.288
Mutt, 2012, Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D(3) via the NF-κB pathway, FASEB J, 26, 4400, 10.1096/fj.12-210880
Schooling, 2013, Mendelian randomization estimates may be inflated, J Am Coll Cardiol, 61, 1931, 10.1016/j.jacc.2012.12.049
Skaaby, 2013, Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach, PLoS One, 8, e57647, 10.1371/journal.pone.0057647